Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-10-11 4:31 pm Purchase |
2022-09-28 | 13D | Gemini Therapeutics, Inc. GMTX |
ADAGE CAPITAL PARTNERS GP L.L.C. | 250,000 5.780% |
181,739 (+266.24%) |
Filing History |
| 2022-08-12 4:46 pm Unchanged |
2022-08-09 | 13D | Gemini Therapeutics, Inc. GMTX |
FS Development Holdings LLC | 487,025 11.260% |
0 (Unchanged) |
Filing History |
| 2022-04-13 4:11 pm Purchase |
2022-04-11 | 13G | Gemini Therapeutics, Inc. GMTX |
BML Investment Partners, L.P. | 527,000 12.200% |
294,030 (+126.21%) |
Filing History |
| 2022-03-10 2:01 pm Unchanged |
2022-03-04 | 13G | Gemini Therapeutics, Inc. GMTX |
BML Investment Partners, L.P. | 232,970 5.400% |
0 (Unchanged) |
Filing History |
| 2022-03-10 1:16 pm Purchase |
2022-03-04 | 13G | Gemini Therapeutics, Inc. GMTX |
BML Investment Partners, L.P. | 232,970 5.400% |
232,970 (New Position) |
Filing History |
| 2022-02-14 4:54 pm Sale |
2021-12-31 | 13G | Gemini Therapeutics, Inc. GMTX |
Alyeska Investment Group, L.P. | 0 0.000% |
-84,605 (Position Closed) |
Filing History |
| 2022-02-11 4:47 pm Purchase |
2021-12-31 | 13G | Gemini Therapeutics, Inc. GMTX |
SUVRETTA CAPITAL MANAGEMENT, LLC | 237,227 5.500% |
13,942 (+6.24%) |
Filing History |
| 2022-02-10 08:45 am Purchase |
2021-12-31 | 13G | Gemini Therapeutics, Inc. GMTX |
ADAGE CAPITAL PARTNERS GP L.L.C. | 68,261 1.580% |
68,261 (New Position) |
Filing History |
| 2022-02-04 09:26 am Sale |
2021-12-31 | 13G | FS DEV CORP COM FSDC |
Wellington Management Group LLP | 0 0.000% |
-990,000 (Position Closed) |
Filing History |
| 2022-02-04 08:01 am Unchanged |
2021-12-31 | 13G | Gemini Therapeutics, Inc. GMTX |
Hawkes Bay Master Investors (Cayman) L.P. | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2022-02-03 2:36 pm Purchase |
2021-12-31 | 13G | Gemini Therapeutics, Inc. GMTX |
FRANKLIN RESOURCES INC BEN |
251,277 5.800% |
251,277 (New Position) |
Filing History |
| 2022-01-31 9:02 pm Unchanged |
2021-12-31 | 13G | Gemini Therapeutics, Inc. GMTX |
Opaleye Management Inc. | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2021-10-15 4:49 pm Purchase |
2021-10-05 | 13G | Gemini Therapeutics, Inc. GMTX |
SUVRETTA CAPITAL MANAGEMENT, LLC | 223,284 5.200% |
223,284 (New Position) |
Filing History |
| 2021-02-22 3:47 pm Purchase |
2021-02-05 | 13D | Gemini Therapeutics, Inc. GMTX |
ORBIMED ADVISORS LLC | 582,622 12.900% |
582,622 (New Position) |
Filing History |
| 2021-02-16 5:28 pm Purchase |
2021-02-05 | 13D | Gemini Therapeutics, Inc. GMTX |
Lightstone Ventures L.P. | 483,611 10.700% |
483,611 (New Position) |
Filing History |
| 2021-02-16 5:25 pm Purchase |
2021-02-05 | 13D | Gemini Therapeutics, Inc. GMTX |
Atlas Venture Fund X L.P. | 401,505 8.900% |
401,505 (New Position) |
Filing History |
| 2021-02-16 11:21 am Purchase |
2020-12-31 | 13G | Gemini Therapeutics, Inc. GMTX |
Alyeska Investment Group, L.P. | 84,605 6.800% |
84,605 (New Position) |
Filing History |
| 2021-02-12 5:20 pm Purchase |
2020-12-31 | 13G | FS DEV CORP COM FSDC |
Opaleye Management Inc. | 704,400 5.630% |
36,000 (+5.39%) |
Filing History |
| 2021-02-12 4:39 pm Purchase |
2021-02-05 | 13D | Gemini Therapeutics, Inc. GMTX |
FS Development Holdings LLC | 487,025 10.750% |
487,025 (New Position) |
Filing History |
| 2021-02-04 11:19 am Purchase |
2020-12-31 | 13G | FS DEV CORP COM FSDC |
Wellington Management Group LLP | 990,000 7.910% |
990,000 (New Position) |
Filing History |